Current Atherosclerosis Reports

Papers
(The TQCC of Current Atherosclerosis Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions101
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management91
Revascularization Options for Left Main Disease: What Clinicians Need to Know77
Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation69
Dietary Influences on Atherosclerotic Cardiovascular Disease Risk59
Pericoronary Fat Attenuation: Diagnosis and Clinical Implications57
Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus55
An Update on Nutrition Guidance for Cardiovascular Health49
Gene Regulatory Networks in Coronary Artery Disease47
A Potential Role for MAGI-1 in the Bi-Directional Relationship Between Major Depressive Disorder and Cardiovascular Disease47
Social Phenotyping for Cardiovascular Risk Stratification in Electronic Health Registries46
Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?46
The Role of Social Determinants of Health in Atherosclerotic Cardiovascular Disease45
Is There a Role for Imaging Youth at Risk of Atherosclerosis?44
Homozygous Familial Hypercholesterolemia Treatment: New Developments44
Statin Use and Coronary Artery Calcification: a Systematic Review and Meta-analysis of Observational Studies and Randomized Controlled Trials42
Impact of Climate Change on Cardiovascular Health41
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?40
Understanding Immigration as a Social Determinant of Health: Cardiovascular Disease in Hispanics/Latinos and South Asians in the United States40
Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention39
Apolipoprotein E and Atherosclerosis35
Gene-Environment Interactions for Cardiovascular Disease34
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors32
Free Cholesterol Bioavailability and Atherosclerosis31
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?30
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis30
Saturated Fat and Cardiovascular Health: Phenotype and Dietary Factors Influencing Interindividual Responsiveness29
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?29
COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave28
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know28
Social Media and Cardiovascular Health: Implications for Women28
The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular Health27
Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology27
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?27
T-cell Cholesterol Accumulation, Aging, and Atherosclerosis26
Can Surrogate Markers Help Define Cardiovascular Disease in Youth?26
LDL Transcytosis by the Arterial Endothelium—Atherosclerosis by a Thousand Cuts?26
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis25
Gene Editing for the Treatment of Hypercholesterolemia25
Do Statins Affect Cognitive Health? A Narrative Review and Critical Analysis of the Evidence25
Bridging the Gap: How Accounting for Social Determinants of Health Can Improve Digital Health Equity in Cardiovascular Medicine24
Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination24
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis23
Coconut Oil and Cardiovascular Disease Risk23
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment23
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference23
Ultra-processed Foods and Cardiometabolic Health Outcomes: from Evidence to Practice23
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine22
Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?21
Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?21
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?21
Risk Factors Favoring Plaque Erosion20
Targeting the Gut Microbiome to Treat Cardiometabolic Disease20
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?20
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field19
The Use of Retinal Imaging Including Fundoscopy, OCT, and OCTA for Cardiovascular Risk Stratification and the Detection of Subclinical Atherosclerosis19
Best Practices for Designing Informative Trials Including Women19
Targeting Macrophage Phenotypes and Metabolism as Novel Therapeutic Approaches in Atherosclerosis and Related Cardiovascular Diseases18
Transintestinal cholesterol excretion in health and disease18
Natural Sirtuin1 Activators and Atherosclerosis: an Overview18
Myocardial Bridge and Atherosclerosis, an Intimal Relationship18
Cardiovascular Health and Disease in the Pakistani American Population18
Coronary Artery Disease Risk Prediction in Young Adults: How Can We Overcome the Dominant Effect of Age?17
Sex Differences in Coronary Atherosclerosis17
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician17
What Causes Premature Coronary Artery Disease?17
Atherosclerosis in Systemic Lupus Erythematosus17
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population17
Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering Therapy16
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management16
Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials15
Time-Restricted Eating to Improve Cardiovascular Health15
RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases14
Improving Maternal Cardiovascular Health in Underserved Populations: a Narrative Review of Behavioral Intervention Trials Targeting Postpartum Weight Retention14
Plant- and Animal-Based Protein-Rich Foods and Cardiovascular Health14
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men14
Next Generation Risk Markers in Preventive Cardio-oncology14
Update on Sitosterolemia and Atherosclerosis14
Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment13
Machine Learning in Invasive and Noninvasive Coronary Angiography13
Mechanisms Behind NAFLD: a System Genetics Perspective13
Bempedoic Acid: for Whom and When13
IL-6 and Cardiovascular Risk: A Narrative Review13
Cholesterol Screening in Children: Is a Universal Approach Working?13
Family Meals and Cardiometabolic Risk Factors in Young Children13
The Effects of FABP4 on Cardiovascular Disease in the Aging Population13
The Pandemic of Coronary Artery Disease in the Sub-Saharan Africa: What Clinicians Need to Know13
Childhood Obesity and Cardiovascular Disease Risk13
Behavioral Medicine for Sedentary Behavior, Daily Physical Activity, and Exercise to Prevent Cardiovascular Disease: A Review12
Moving the Paradigm Forward for Prediction and Risk-Based Primary Prevention of Heart Failure in Special Populations12
ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets12
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?12
Ambient Air Pollution and Atherosclerosis: Recent Updates12
0.29827904701233